These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22547545)

  • 21.
    Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
    Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
    Zhang Y; Bliska JB
    Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
    Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
    Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution and virulence contributions of the autotransporter proteins YapJ and YapK of Yersinia pestis CO92 and their homologs in Y. pseudotuberculosis IP32953.
    Lenz JD; Temple BR; Miller VL
    Infect Immun; 2012 Oct; 80(10):3693-705. PubMed ID: 22802344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM.
    Chung LK; Philip NH; Schmidt VA; Koller A; Strowig T; Flavell RA; Brodsky IE; Bliska JB
    mBio; 2014 Jul; 5(4):e01402-14. PubMed ID: 24987096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
    Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
    PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes.
    Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J
    PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
    Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
    Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.
    Trülzsch K; Sporleder T; Igwe EI; Rüssmann H; Heesemann J
    Infect Immun; 2004 Sep; 72(9):5227-34. PubMed ID: 15322017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of chromosomal regions conserved in Yersinia pseudotuberculosis and lost by Yersinia pestis.
    Pouillot F; Fayolle C; Carniel E
    Infect Immun; 2008 Oct; 76(10):4592-9. PubMed ID: 18678673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.
    Pouillot F; Fayolle C; Carniel E
    Microbiology (Reading); 2007 Aug; 153(Pt 8):2426-2434. PubMed ID: 17660407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.
    Miller HK; Schwiesow L; Au-Yeung W; Auerbuch V
    Front Cell Infect Microbiol; 2016; 6():69. PubMed ID: 27446816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
    Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
    Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current activities of the Yersinia effector protein YopM.
    Höfling S; Grabowski B; Norkowski S; Schmidt MA; Rüter C
    Int J Med Microbiol; 2015 May; 305(3):424-32. PubMed ID: 25865799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route.
    Pisano F; Heine W; Rosenheinrich M; Schweer J; Nuss AM; Dersch P
    PLoS One; 2014; 9(7):e103541. PubMed ID: 25075520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.
    Schiano CA; Bellows LE; Lathem WW
    Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis.
    Champion OL; Cooper IAM; James SL; Ford D; Karlyshev A; Wren BW; Duffield M; Oyston PCF; Titball RW
    Microbiology (Reading); 2009 May; 155(Pt 5):1516-1522. PubMed ID: 19383703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing.
    LaRock CN; Cookson BT
    Cell Host Microbe; 2012 Dec; 12(6):799-805. PubMed ID: 23245324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
    Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
    Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.